First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma
Clinical trial NCT01828034 · COMPLETED
Trial details
- NCT number
- NCT01828034
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2019-05-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.